FPWM
BMY icon

FSB Premier Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

FSB Premier Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Sell
6,061
-377
-6% -$21.6K 0.1% 186
2026
Q1 		$390K Buy
+6,438
New +$375K 0.12% 160
2022
Q1 		– Sell
-2,655
Closed -$165K – 176
2021
Q4 		$165K Buy
+2,655
New +$156K 0.07% 137

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FSB Premier Wealth Management's BMY Position: Q2 2026 in Review

FSB Premier Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 5.9% in Q2 2026, selling an estimated $21.6K and leaving 6,061 shares worth $349K. The position accounts for 0.1% of the portfolio, ranked #186.

FSB Premier Wealth Management first reported a position in BMY in Q4 2021 and has held it in 3 quarters since. The position peaked at $390K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • FSB Premier Wealth Management held 6,061 shares of Bristol-Myers Squibb worth $349K as of Q2 2026.
  • FSB Premier Wealth Management sold 377 Bristol-Myers Squibb shares in Q2 2026, an estimated $21.6K.
  • Bristol-Myers Squibb made up 0.1% of FSB Premier Wealth Management's portfolio in Q2 2026, its #186 holding.
  • FSB Premier Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 3 quarters since.
  • FSB Premier Wealth Management's Bristol-Myers Squibb position peaked at $390K in Q1 2026.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on FSB Premier Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.